Tamsulosin and iris pigmentation.
Julio
J
González Martín-Moro
Fernando Gómez
FG
Sanz
Francisco J
FJ
Munoz-Negrete
D058668:Adrenergic alpha-1 Receptor Antagonists / Q000494:pharmacology*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000886:Anthropometry; D002387:Cataract Extraction; D004305:Dose-Response Relationship, Drug; D006801:Humans; D017496:Hypopigmentation / Q000209:etiology; D007431:Intraoperative Complications; D007498:Iris / Q000187:drug effects* / Q000473:pathology; D008297:Male; D008543:Melanins / Q000378:metabolism; D009130:Muscle, Smooth / Q000187:drug effects* / Q000473:pathology; D010857:Pigment Epithelium of Eye / Q000187:drug effects* / Q000378:metabolism; D011470:Prostatic Hyperplasia / Q000188:drug therapy; D017154:Stromal Cells / Q000187:drug effects; D013449:Sulfonamides / Q000494:pharmacology*; D013577:Syndrome; D000077409:Tamsulosin
D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists; D008543:Melanins; D013449:Sulfonamides; D000077409:Tamsulosin